SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is currently trending as its dedicated community remains highly engaged, actively accumulating the asset and expressing strong conviction despite broader market volatility. Chatter is focused on its role as the "Face of Base" and anticipation of future catalysts like potential Tier 1 exchange listings and the upcoming Toshi Mobile launch, reinforcing its long-term utility beyond a meme coin.

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

Immucell Corp.

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Exact Sciences Corp.

Exact Sciences is trending following its acquisition by Abbott Laboratories for $105 per share, a deal valued at approximately $21 billion. The community is actively discussing this major development in the cancer diagnostics sector, with many celebrating substantial long-term gains while evaluating their next investment moves given the significant buyout offer.

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Quoin Pharmaceuticals is trending after announcing the successful achievement of target rapamycin loadings for two proprietary topical delivery technologies, advancing its rare disease pipeline. This news, coupled with its extremely low float and recent significant private placement funding, is driving intense community speculation about a potential short squeeze. Traders are actively debating its volatile price action and the possibility of substantial upside, comparing its potential to other low-float runners.

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Protagonist Therapeutics Inc

Protagonist Therapeutics is trending due to significant market chatter surrounding a potential acquisition by Johnson & Johnson, complementing its strong clinical pipeline. The community is highly engaged in discussions about J&J's strategic interest in PTGX's promising immunology and hematology assets, particularly the "practice-changing" rusfertide data and the efficacy of its oral IL-23 receptor antagonist, JNJ-2113.

Colliers International Group, Inc. engages in the provision of commercial real estate services to corporate and institutional clients. It offers outsourcing and advisory services, lease brokerage, and sales brokerage. It operates through the following segments: Real Estate Services, Engineering, Investment Management, and Corporate. The Real Estate Services segment relates to Americas, EMEA, and Asia Pacific regions. The Engineering segment refers to engineering and project management. The Investment Management segment is involved in a global alternative asset manager with long-standing, cycle tested expertise. The Corporate segment includes the costs of global administrative functions and corporate head office. The company was founded on July 31, 1988, and is headquartered in Toronto, Canada.

Colliers International Group Inc

Colliers International (CIGI) is trending due to its strategic partnership with Google Cloud, aimed at accelerating digital and AI-powered innovation within the commercial real estate sector. The community sees this as a pivotal move into AI infrastructure, positioning Colliers for market leadership in this evolving space. Ongoing analyst interest is also evident, reflecting the company's broader strategy of diversifying services through targeted acquisitions.

The Middleby Corp. engages in the design, manufacture, marketing, and distribution of foodservice equipment. It operates through the following segments: Commercial Foodservice Equipment Group, Food Processing Equipment Group, Residential Kitchen Equipment Group, and Corporate and Other. The Commercial Foodservice Equipment Group segment manufactures, sells, and distributes foodservice equipment for the restaurant and institutional kitchen industry. The Food Processing Equipment Group segment manufactures preparation, cooking, packaging, food handling, and food safety equipment for the food processing industry. The Residential Kitchen Equipment Group segment manufactures, sells, and distributes kitchen equipment such as cookers, stoves, ovens, refrigerators, dishwashers, microwaves, cooktops, wine coolers, ice machines, ventilation, and outdoor equipment for the residential market. The Corporate and Other segment refers to the corporate and other general company assets and operations. The company was founded in 1888 and is headquartered in Elgin, IL.

Middleby Corp.

Middleby Corp ($MIDD) is trending amid significant insider buying, with director Edward Garden recently investing millions, signaling confidence in the company's future. Community discussions also highlight the company's recent earnings beat, spin-off plans, and potential for long-term growth within the kitchen technology and food processing sectors. Analyst ratings are mixed, with some firms adjusting price targets and ratings, adding to the stock's current buzz.

Codatta

XNY CRYPTO, Codatta, is generating significant community excitement due to its recent strong price action and notable resilience amidst broader market fluctuations. Investors are actively discussing its underlying utility as a decentralized data marketplace for AI and scientific research, where data contributors earn royalties, leading to speculation that this once-overlooked asset is building momentum for further gains.

Listed Funds Trust - Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF ($XXRP) is trending as traders discuss its potential for amplified gains relative to XRP, especially with upcoming crypto ETFs and regulatory developments on the horizon. Community members are actively trading the ETF, looking for quick profits and highlighting the importance of timing. Some traders caution about the ETF's decay and its unsuitability for long-term holding.

SoftBank Group Corp. operates as a holding company which engages in the management of its group companies. It operates through the following segments: SoftBank Vision Fund, SoftBank, Arm, Brightstar, and Others. The SoftBank Vision Fund segment engages in the investment business. The SoftBank segment provides mobile communication, broadband, and telecom services in Japan. The Arm segment designs microprocessors and develops software technologies. The Brightstar segment engages in the distribution of mobile devices overseas. The Others segment includes the smartphone payments business, alternative investment business, fund business in Latin America and the operation of baseball teams. The company was founded by Masayoshi Son on September 3, 1981 and is headquartered in Tokyo, Japan.

SoftBank Group Corp. - ADR

SoftBank Corp.

SoftBank is actively trending due to its aggressive pursuit of artificial intelligence dominance, highlighted by significant planned investments in U.S. data center facilities for OpenAI's Stargate project and Masayoshi Son's reported push for a substantial AI chip development venture. Community discussion centers on SoftBank's strategic asset divestments, including an Nvidia stake, to fund these expansive AI initiatives and leverage its Arm Holdings ownership. This reflects SoftBank's accelerated drive to lead in next-generation AI infrastructure and computing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CAPR  I cannot imagine how humiliated / bitter Prasad must feel right now… he literally put Verdun on leave for her objection to cancel the adcomm…  Verdun would be 100x more qualified as the head of CBER!!! Prasad is a joke… anyway, I believe $QURE $REPL will benefit from the positive hope3 result as well.

Ms P

Finli

Veg Green

John Albrecht

Novice

Arclyte

Phantom_Dancer

Nbclean

It has been an incredibly difficult yr for me… holding $CAPR has been such a nerve racking experience …literally like a never-ending nightmare. one drama after another…. Glad today we finally see the light! The battle hasn’t ended yet. Let’s hope Prasad will admit his “defeat” or “mistake”. Besides, Prasad the CLOWN cut my most profitable investment $QURE by more than a half. Hope he will do a reverse asap.

StockTwits for iOS

tttggg

Capricor Therapeutics Inc

uniQure NV

Replimune Group Inc

  I cannot imagine how humiliated / bitter Prasad must feel right now… he literally put Verdun on leave for her objection to cancel the adcomm…  Verdun would be 100x more qualified as the head of CBER!!! Prasad is a joke… anyway, I believe 

 will benefit from the positive hope3 result as well.